IP Library Assignment 038274/0353
Patent Assignment
Reel/Frame 038274/0353

Change of Name

Recorded: 2016-03-28 Pages: 4
Assignor
ALDEXA THERAPEUTICS, INC.
Executed: 2014-03-17
Assignee
ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Patent: 9,364,471 →
Application: 14/581,453 →
Publication: US 2015/0209333
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 28, 2016
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 038111/0288 →
Change of Address of Assignee Mar 28, 2016
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 038274/0333 →
Change of Name Mar 28, 2016
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 038274/0345 →
Security Interest Dec 7, 2016
From: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 040589/0196 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →